Localization of the active site of human tumour necrosis factor (hTNF) by mutational analysis
about
DeltaBAFF, an alternate splice isoform that regulates receptor binding and biopresentation of the B cell survival cytokine, BAFFA tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activityIdentification of receptor-binding domains on human interleukin 5 and design of an interleukin 5-derived receptor antagonist.A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone lossDevelopment of a novel DDS for site-specific PEGylated proteins.Molecular design of hybrid tumour necrosis factor alpha with polyethylene glycol increases its anti-tumour potency.Polymorphism of murine Fas ligand that affects the biological activityFunctional characterization of the human tumor necrosis factor receptor p75 in a transfected rat/mouse T cell hybridoma.Induced expression of trimerized intracellular domains of the human tumor necrosis factor (TNF) p55 receptor elicits TNF effects.Characterization of the complex formed between a potent neutralizing ovine-derived polyclonal anti-TNFα Fab fragment and human TNFα.Dissociation of TNF-alpha cytotoxic and proinflammatory activities by p55 receptor- and p75 receptor-selective TNF-alpha mutants.Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.Molecular cloning and characterization of beluga whale (Delphinapterus leucas) interleukin-1beta and tumor necrosis factor-alpha.Potency-matched Dual Cytokine-Antibody Fusion Proteins for Cancer Therapy.Chemical modification of natural human tumor necrosis factor-alpha with polyethylene glycol increases its anti-tumor potency.
P2860
Q24309087-7DC11353-1141-4D22-9505-5BE408FFF18DQ24675629-CF840508-D5F9-4AEA-91A0-66278AB633D0Q34297178-45BB691D-43D9-467F-8043-365AC1F81276Q34567407-A1FE287B-060C-4C87-8112-0B9CC0E40536Q35040200-248547F9-33AC-4B61-91D9-8FC30AB89273Q36080891-6FD4C4F4-82BC-4D0B-B439-97811D3E6F4AQ36107352-799BBD38-F44D-4A0E-AE3B-43E5463F2CDDQ36231848-52053FD9-E212-4DEA-A503-01EB5001BAEFQ36266899-918CC919-2F75-4B6A-B7F0-9A6930BC8BE8Q37126944-C143D7D9-2CBB-4064-8DF5-F90E7FC984E1Q37628836-E5F87643-48BC-4697-AD06-C194461BDE6EQ37629829-92FE1EC9-9FB1-4772-A490-EA1F1FDCD13DQ41958411-88940FAD-C71D-4FAD-9F45-44773BF4C42AQ50885364-AF4D737B-C3A2-4E90-8181-BA9A61F08C72Q54941968-EC3728BB-CF8F-49AB-A7A3-347A1E303061
P2860
Localization of the active site of human tumour necrosis factor (hTNF) by mutational analysis
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Localization of the active sit ...... (hTNF) by mutational analysis
@ast
Localization of the active sit ...... (hTNF) by mutational analysis
@en
type
label
Localization of the active sit ...... (hTNF) by mutational analysis
@ast
Localization of the active sit ...... (hTNF) by mutational analysis
@en
prefLabel
Localization of the active sit ...... (hTNF) by mutational analysis
@ast
Localization of the active sit ...... (hTNF) by mutational analysis
@en
P2093
P2860
P1433
P1476
Localization of the active sit ...... (hTNF) by mutational analysis
@en
P2093
P2860
P304
P407
P577
1991-04-01T00:00:00Z